TY - JOUR
T1 - Only slow decline in exercise capacity in the natural history of patients with congenital heart disease
T2 - A longitudinal study in 522 patients
AU - Müller, Jan
AU - Ewert, Peter
AU - Hager, Alfred
N1 - Publisher Copyright:
© The European Society of Cardiology 2013.
PY - 2015/1/19
Y1 - 2015/1/19
N2 - Objective: Exercise studies in patients with congenital heart disease (CHD) suggest that exercise capacity declines progressively. This study aims to assess the natural history of exercise capacity in patients with CHD from serial cardiopulmonary exercise tests (CPETs) and to identify factors that are associated with the rate of decrease. Patients and methods: From July 2001-August 2012 we included all patients with CHD who had two CPETs separated by at least six months. Patients with any kind of intervention (surgery, catheter intervention, or change in medication) between the two tests were excluded. Results: In 522 patients (24.8 ± 10.2 years, 215 female) peak oxygen uptake (VO2) was reduced to 80.0 ± 20.7% predicted and declined significantly during a mean follow-up of 2.5 ± 1.8 years to 78.1 ± 20.4% predicted (p < 0.0001). The annual declining rate of peak VO2 was only -1.01 ± 6.83% points per year. Higher peak oxygen pulse (% predicted) (r = -0.230; p < 0.0001), higher peak VO2 (% predicted) (r = -0.213; p < 0.0001) at baseline testing and the presence of a pacemaker (r = -0.095; p = 0.031) were only weakly associated with a more rapid decline in peak VO2 (% predicted) over time. The decline was independent from diagnosis, heart defect severity, systemic ventricular morphology and age. Conclusions: There was a progressive, but slow, decline in the natural history of exercise capacity in all kind of patients with CHD. Except for having a pacemaker, we could not find any factors associated with this decline.
AB - Objective: Exercise studies in patients with congenital heart disease (CHD) suggest that exercise capacity declines progressively. This study aims to assess the natural history of exercise capacity in patients with CHD from serial cardiopulmonary exercise tests (CPETs) and to identify factors that are associated with the rate of decrease. Patients and methods: From July 2001-August 2012 we included all patients with CHD who had two CPETs separated by at least six months. Patients with any kind of intervention (surgery, catheter intervention, or change in medication) between the two tests were excluded. Results: In 522 patients (24.8 ± 10.2 years, 215 female) peak oxygen uptake (VO2) was reduced to 80.0 ± 20.7% predicted and declined significantly during a mean follow-up of 2.5 ± 1.8 years to 78.1 ± 20.4% predicted (p < 0.0001). The annual declining rate of peak VO2 was only -1.01 ± 6.83% points per year. Higher peak oxygen pulse (% predicted) (r = -0.230; p < 0.0001), higher peak VO2 (% predicted) (r = -0.213; p < 0.0001) at baseline testing and the presence of a pacemaker (r = -0.095; p = 0.031) were only weakly associated with a more rapid decline in peak VO2 (% predicted) over time. The decline was independent from diagnosis, heart defect severity, systemic ventricular morphology and age. Conclusions: There was a progressive, but slow, decline in the natural history of exercise capacity in all kind of patients with CHD. Except for having a pacemaker, we could not find any factors associated with this decline.
KW - Congenital heart disease
KW - Exercise capacity
KW - Exercise testing
KW - Natural history
KW - Peak oxygen uptake
KW - Serial study
UR - http://www.scopus.com/inward/record.url?scp=84918588308&partnerID=8YFLogxK
U2 - 10.1177/2047487313505242
DO - 10.1177/2047487313505242
M3 - Article
C2 - 24042855
AN - SCOPUS:84918588308
SN - 2047-4873
VL - 22
SP - 113
EP - 118
JO - European Journal of Preventive Cardiology
JF - European Journal of Preventive Cardiology
IS - 1
ER -